Lot-to-Lot Variability in Biologics and Biosimilars: What It Means for Patients and Providers
Lot-to-lot variability is normal in biologics and biosimilars due to their complex biological production. Unlike generics, biosimilars aren't identical copies but are proven safe and effective despite natural variations. Learn how this affects patients, labs, and drug access.
View More